Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
Brown, Jennifer R, Moslehi, Javid, O'Brien, Susan, Ghia, Paolo, Hillmen, Peter, Cymbalista, Florence, Shanafelt, Tait D, Fraser, Graeme, Rule, Simon, Kipps, Thomas J, Coutre, Steven, Dilhuydy, Marie-Sarah, Cramer, Paula, Tedeschi, Alessandra, Jaeger, Ulrich, Dreyling, Martin, Byrd, John C, Howes, Angela, Todd, Michael, Vermeulen, Jessica, James, Danelle F, Clow, Fong, Styles, Lori, Valentino, Rudy, Wildgust, Mark, Mahler, Michelle, Burger, Jan A
Published in Haematologica (Roma) (01.10.2017)
Published in Haematologica (Roma) (01.10.2017)
Get full text
Journal Article
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older
Harousseau, Jean-Luc, Martinelli, Giovanni, Jedrzejczak, Wieslaw W., Brandwein, Joseph M., Bordessoule, Dominique, Masszi, Tamas, Ossenkoppele, Gert J., Alexeeva, Julia A., Beutel, Gernot, Maertens, Johan, Vidriales, Maria-Belen, Dombret, Hervé, Thomas, Xavier, Burnett, Alan K., Robak, Tadeusz, Khuageva, Nuriet K., Golenkov, Anatoly K., Tothova, Elena, Mollgard, Lars, Park, Youn C., Bessems, Annick, De Porre, Peter, Howes, Angela J.
Published in Blood (06.08.2009)
Published in Blood (06.08.2009)
Get full text
Journal Article
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open‐label phase 3 study
Huang, Xiaojun, Qiu, Lugui, Jin, Jie, Zhou, Daobin, Chen, Xiequn, Hou, Ming, Hu, Jianda, Hu, Yu, Ke, Xiaoyan, Li, Junmin, Liang, Yingmin, Liu, Ting, Lv, Yue, Ren, Hanyun, Sun, Aining, Wang, Jianmin, Zhao, Chunting, Salman, Mariya, Sun, Steven, Howes, Angela, Wang, Jingzhao, Wu, Peng, Li, Jianyong
Published in Cancer medicine (Malden, MA) (01.04.2018)
Published in Cancer medicine (Malden, MA) (01.04.2018)
Get full text
Journal Article
Phase II Study of the Efficacy and Tolerability of Two Dosing Regimens of the Farnesyl Transferase Inhibitor, R115777, in Advanced Breast Cancer
JOHNSTON, Stephen R. D, HICKISH, Tamas, HOWES, Angela, ELLIS, Paul, HOUSTON, Stephen, KELLAND, Lloyd, DOWSETT, Mitch, SALTER, Janine, MICHIELS, Bart, PEREZ-RUIXO, Juan Jose, PALMER, Peter
Published in Journal of clinical oncology (01.07.2003)
Published in Journal of clinical oncology (01.07.2003)
Get full text
Journal Article
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy
Johnston, Stephen R. D., Semiglazov, Vladimir F., Manikhas, George M., Spaeth, Dominique, Romieu, Gilles, Dodwell, David J., Wardley, Andrew M., Neven, Patrick, Bessems, Annick, Park, Youn C., De Porre, Peter M., Perez Ruixo, Juan J., Howes, Angela J.
Published in Breast cancer research and treatment (01.07.2008)
Published in Breast cancer research and treatment (01.07.2008)
Get full text
Journal Article
The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo
Martin, Lesley-Ann, Head, Julia E, Pancholi, Sunil, Salter, Janine, Quinn, Emma, Detre, Simone, Kaye, Stan, Howes, Angela, Dowsett, Mitch, Johnston, Stephen R D
Published in Molecular cancer therapeutics (01.09.2007)
Published in Molecular cancer therapeutics (01.09.2007)
Get full text
Journal Article
Preclinical Antitumor Activity and Pharmacodynamic Studies with the Farnesyl Protein Transferase Inhibitor R115777 in Human Breast Cancer
KELLAND, Lloyd R, SMITH, Vicki, JOHNSTON, Stephen R. D, VALENTI, Melanie, PATTERSON, Lisa, CLARKE, Paul A, DETRE, Simone, END, Dave, HOWES, Angela J, DOWSETT, Mitch, WORKMAN, Paul
Published in Clinical cancer research (01.11.2001)
Get full text
Published in Clinical cancer research (01.11.2001)
Journal Article
Comparison of the Systemic and Intratumoral Effects of Tamoxifen and the Aromatase Inhibitor Vorozole in Postmenopausal Patients With Primary Breast Cancer
Catherine L. Harper-Wynne, Nigel P.M. Sacks, Karyn Shenton, Fiona A. MacNeill, Paul Sauven, Ian J. Laidlaw, Zen Rayter, Stephanie Miall, Angela Howes, Janine Salter, Margaret J. Hills, Frances M. Lowe, Roger A’Hern, Nazar Nasiri, Debbie Doody, Jhangir Iqbal, Mitchell Dowsett
Published in Journal of clinical oncology (15.02.2002)
Published in Journal of clinical oncology (15.02.2002)
Get full text
Journal Article
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
Wang, Michael L., Jurczak, Wojciech, Jerkeman, Mats, Trotman, Judith, Zinzani, Pier L., Belada, David, Boccomini, Carola, Flinn, Ian W., Giri, Pratyush, Goy, Andre, Hamlin, Paul A., Hermine, Olivier, Hernández-Rivas, José-Ángel, Hong, Xiaonan, Kim, Seok Jin, Lewis, David, Mishima, Yuko, Özcan, Muhit, Perini, Guilherme F., Pocock, Christopher, Song, Yuqin, Spurgeon, Stephen E., Storring, John M., Walewski, Jan, Zhu, Jun, Qin, Rui, Henninger, Todd, Deshpande, Sanjay, Howes, Angela, Le Gouill, Steven, Dreyling, Martin
Published in The New England journal of medicine (30.06.2022)
Published in The New England journal of medicine (30.06.2022)
Get full text
Journal Article
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study
Chanan-Khan, Asher, Prof, Cramer, Paula, MD, Demirkan, Fatih, MD, Fraser, Graeme, MD, Silva, Rodrigo Santucci, MD, Grosicki, Sebastian, Prof, Pristupa, Aleksander, MD, Janssens, Ann, MD, Mayer, Jiri, Prof, Bartlett, Nancy L, Prof, Dilhuydy, Marie-Sarah, MD, Pylypenko, Halyna, MD, Loscertales, Javier, MD, Avigdor, Abraham, MD, Rule, Simon, Prof, Villa, Diego, MD, Samoilova, Olga, MD, Panagiotidis, Panagiots, Prof, Goy, Andre, MD, Mato, Anthony, MD, Pavlovsky, Miguel A, MD, Karlsson, Claes, MD, Mahler, Michelle, MD, Salman, Mariya, PhD, Sun, Steven, PhD, Phelps, Charles, MS, Balasubramanian, Sriram, PhD, Howes, Angela, PhD, Hallek, Michael, MD
Published in The lancet oncology (01.02.2016)
Published in The lancet oncology (01.02.2016)
Get full text
Journal Article
Fixed-duration ibrutinib–venetoclax versus chlorambucil–obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
Niemann, Carsten U, Munir, Talha, Moreno, Carol, Owen, Carolyn, Follows, George A, Benjamini, Ohad, Janssens, Ann, Levin, Mark-David, Robak, Tadeusz, Simkovic, Martin, Voloshin, Sergey, Vorobyev, Vladimir, Yagci, Munci, Ysebaert, Loic, Qi, Keqin, Qi, Qianya, Sinet, Pierre, Parisi, Lori, Srinivasan, Srimathi, Schuier, Natasha, Baeten, Kurt, Howes, Angela, Caces, Donne Bennett, Kater, Arnon P
Published in The lancet oncology (01.12.2023)
Published in The lancet oncology (01.12.2023)
Get full text
Journal Article
CULMINATE: A phase II study of cusatuzumab + azacitidine in patients with newly diagnosed AML, ineligible for intensive chemotherapy
Trudel, Geralyn Carol, Howes, Angela J., Jeste, Neelum, Tryon, Jeffrey J., Xiu, Liang, Kane, Colleen, Nottage, Kerri
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study
Munir, Talha, Moreno, Carol, Owen, Carolyn, Follows, George, Benjamini, Ohad, Janssens, Ann, Levin, Mark-David, Osterborg, Anders, Robak, Tadeusz, Simkovic, Martin, Stevens, Don, Voloshin, Sergey, Vorobyev, Vladimir, Yagci, Munci, Ysebaert, Loic, Qi, Keqin, Qi, Qianya, Parisi, Lori, Srinivasan, Srimathi, Schuier, Natasha, Baeten, Kurt, Howes, Angela, Caces, Donne Bennett, Niemann, Carsten U, Kater, Arnon P
Published in Journal of clinical oncology (20.07.2023)
Published in Journal of clinical oncology (20.07.2023)
Get full text
Journal Article
Residual Disease Kinetics Among Patients with High-Risk Factors Treated with First-Line Fixed-Duration Ibrutinib Plus Venetoclax (Ibr+Ven) Versus Chlorambucil Plus Obinutuzumab (Clb+O): The Glow Study
Niemann, Carsten U, Munir, Talha, Moreno, Carol, Owen, Carolyn, Follows, George A, Benjamini, Ohad, Janssens, Ann, Levin, Mark-David, Österborg, Anders, Robak, Tadeusz, Šimkovič, Martin, Voloshin, Sergey, Vorobyev, Vladimir I., Yagci, Munci, Ysebaert, Loic, Qi, Keqin, Qi, Qianaya, Parisi, Lori, Srinivasan, Srimathi, Schuier, Natasha, Baeten, Kurt, Howes, Angela, Bennett Caces, Donne, Kater, Arnon P.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma
O'Brien, Susan, Hillmen, Peter, Coutre, Steven, Barr, Paul M., Fraser, Graeme, Tedeschi, Alessandra, Burger, Jan A., Dilhuydy, Marie-Sarah, Hess, Georg, Moreno, Carol, Cramer, Paula, Liu, Emily, Chang, Stephen, Vermeulen, Jessica, Styles, Lori, Howes, Angela, James, Danelle F., Patel, Kalpesh, Graef, Thorsten, Valentino, Rudolph
Published in Clinical lymphoma, myeloma and leukemia (01.10.2018)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2018)
Get full text
Journal Article
Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma
Fraser, Graeme A.M., Chanan-Khan, Asher, Demirkan, Fatih, Santucci Silva, Rodrigo, Grosicki, Sebastian, Janssens, Ann, Mayer, Jiri, Bartlett, Nancy L., Dilhuydy, Marie-Sarah, Loscertales, Javier, Avigdor, Abraham, Rule, Simon, Samoilova, Olga, Pavlovsky, Miguel A., Goy, Andre, Mato, Anthony, Hallek, Michael, Salman, Mariya, Tamegnon, Monelle, Sun, Steven, Connor, Anne, Nottage, Kerri, Schuier, Natasha, Balasubramanian, Sriram, Howes, Angela, Cramer, Paula
Published in Leukemia & lymphoma (09.11.2020)
Published in Leukemia & lymphoma (09.11.2020)
Get full text
Journal Article
Safety and Efficacy of Cusatuzumab in Combination with Venetoclax and Azacitidine (CVA) in Patients with Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Eligible for Intensive Chemotherapy; An Open-Label, Multicenter, Phase 1b Study
Roboz, Gail J., Pabst, Thomas, Aribi, Ahmed, Brandwein, Joseph M., Döhner, Hartmut, Fiedler, Walter, Gandini, Domenica, Geddes, Michelle, Hou, Jing-Zhou, Howes, Angela J., Hultberg, Anna, Huselton, Eric, Jacobs, Julie, Kane, Colleen, Lech-Marańda, Ewa, Louwers, Marieke, Nottage, Kerri, Platzbecker, Uwe, Rampal, Raajit, Salman, Mariya, Shah, Priya, Stevens, Don, Stuart, Monic, Subklewe, Marion, Sumbul, Anne, Wang, Eunice S., Wierzbowska, Agnieszka, Yao, Bin, Yee, Karen, Kantarjian, Hagop, Borthakur, Gautam
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Comparing overall survival (OS) outcomes in patients with newly diagnosed chronic lymphocytic leukemia (CLL) with normal life expectancy
Furman, Richard R., Allan, John N, Howes, Angela J., Mahler, Michelle, Wildgust, Mark A.
Published in Journal of clinical oncology (20.01.2016)
Published in Journal of clinical oncology (20.01.2016)
Get full text
Journal Article
Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy
Burke, G A Amos, Beishuizen, Auke, Bhojwani, Deepa, Burkhardt, Birgit, Minard-Colin, Véronique, Norris, Robin E, Kabickova, Edita, Pinarli, F Guclu, Tacyildiz, Nurdan, Howes, Angela, Jong, Jan de, Liu, Grace, Nottage, Kerri, Salman, Mariya, Trixhe, Xavier Woot de, Cairo, Mitchell
Published in Leukemia (01.08.2020)
Published in Leukemia (01.08.2020)
Get full text
Journal Article